null - FindTrial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222519

Enrollment

5000

Registered

2014-06-11

Start date

2014-08-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

investigational material(s) Generic name etc : INN of investigational material : rivaroxaban Therapeutic category code : 333 Anticoagulants Dosage and Administration for Investigational material :

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria:

Design outcomes

Secondary

Measure	Time frame
efficacy safety	—

Primary

Measure	Time frame
efficacy	—

Countries

Europe, Japan, North America, South America

Outcome results